Infection control and the long-term care facility

Consultant Pharmacist

Volumn 21, Issue 6, 2006, Pages 467-480

  Wick, Jeannette Y ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Antibiotic use; Antimicrobial resistance; Asymptomatic bacteriuria; Infection control; Influenza; Methicillin resistant Staphylococcus aureus

Indexed keywords

METICILLIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; DIAGNOSTIC ACCURACY; DRUG UTILIZATION; ECONOMIC ASPECT; GASTROINTESTINAL INFECTION; HAND WASHING; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HOSPITAL PATIENT; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA; LONG TERM CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL COLONIZATION; NONHUMAN; PHARMACIST; PRACTICE GUIDELINE; RESPIRATORY TRACT INFECTION; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; URINARY TRACT INFECTION;

EID: 33749618114     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2006.467     Document Type: Review

References (48)

1. Dormandy T. Hospital infections: past, present and future. Available at http://www.firstscience. com/SITE/ARTICLES/hospital.asp. Accessed March 10, 2006.
2. Wyklicky H, Skopec M. Ignaz Philipp Semmelweis, the prophet of bacteriology. Infect Control 1983;4:367-70.
3. History Learning Site. Joseph Lister. Available at http://www. historylearningsite.co.uk/joseph_lister.htm. Accessed March 10, 2006.
4. Burke JP. Infection control-a problem for patient safety. N Engl J Med 2003;348:651-6.
5. Haley RW, Culver DH, White JW et al. The nationwide nosocomial infection rate. A new need for vital statistics. Am J Epidemiol 1985;121:159-67.
6. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996. A report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1996;24:380-8.
7. Strausbaugh LJ. Emerging health care-associated infections in the geriatric population. Emerg Infect Dis 2001;7:268-71.
8. Centers for Disease Control and Prevention. Introduction to epidemiology. Available at http://www.cdc.gov/excite/classroom/intro_epi.htm. Accessed March 8, 2006.
9. Todar K. Mechanisms of bacterial pathogenicity: colonization and Invasion. In Todar's online textbook of bacteriology. Available at http://textbookofbacteriology.net/colonization.html. Accessed March 8, 2006.
10. Centers for Disease Control and Prevention. Campaign to prevent antimicrobial resistance. Available at http://www.cdc.gov/drugresistance/ healthcare/ha/HASlideSet.pdf. Accessed March 2, 2006.
11. Nicolle LE. Preventing infections in non-hospital settings: long-term care. Emerg Infect Dis 2001;7:205-7.
12. Stevenson KB, Loeb M. Performance improvement in the long-term-care setting: building on the foundation of infection control. Infect Control Hosp Epidemiol 2004;25:72-9.
13. Richards CL Jr. Preventing antimicrobial-resistant bacterial infections among older adults in long-term care facilities. J Am Med Dir Assoc 2006;7(3, suppl):S89-S96.
14. Nicolle LE. Infection control in long-term care facilities. Clin Infect Dis 2000;31:752-6.
15. Wenzel RP, The antibiotic pipeline-challenges, costs, and values. N Engl J Med 2004;351:523-6.
16. Weinstein RA. Antibiotic resistance in hospitals and intensive care units: the problem and potential solutions. Semin Respir Crit Care Med 2003;24:113-20.
17. Strausbaugh LJ, Siegel JD, Weinstein RA. Preventing transmission of multidrug-resistant bacteria in health care settings: a tale of 2 guidelines. Clin Infect Dis 2006;42:828-35.
18. Centers for Disease Control and Prevention. Methicillin-resistant Staptylococcus aureus (MRSA). Available at http://www.cdc.gov/ncidod/aip/ research/mrsa.htm. Accessed March 2, 2006.
19. Saravolatz LD, Pohlod DJ, Arking LM. Community-acquired methicillin-resistant Staphylococcus aureus infections: a new source for nosocomial outbreaks. Ann Intern Med 1982;97:325-9.
20. Goldrick BA. Infection control programs in long-term-care facilities: structure and process. Infect Control Hosp Epidemiol 1999;20:764-9.
21. Strausbaugh LJ, Crossley KB, Nurse BA, Thrupp LD. Antimicrobial resistance in long-term-care facilities. Infect Control Hosp Epidemiol 1996;17:129-40.
22. O'Toole RD, Drew WL, Dahlgren BJ, Beaty HN. An outbreak of methicillin-resistant Staphylococcus aureus infection. Observations in hospital and nursing home. JAMA 1970;213:257-63.
23. Gerding DN, Buxton AE, Hughes RA et al. Nosocomial multiply resistant Klebsiella pneumoniae: epidemiology of an outbreak of apparent index case origin. Antimicrob Agents Chemother 1979;15:608-15.
24. Stover BH, Duff A, Adams G et al. Emergence and control of methicillin-resistant Staphylococcus aureus in a children's hospital and pediatric long-term care facility. Am J Infect Control 1992;20:248-55.
25. Graham PL 3rd, Lin SX, Larson EL. A U.S. population-based survey of Staphylococcus aureus colonization. Ann Intern Med 2006;144:318-25.
26. Nicolle LE, Bentley D, Garibaldi R et al. Antimicrobial use in long-term-care facilities. Infect Control Hosp Epidemiol 1996;17:119-28.
27. Norman DC, Toledo SD. Infections in elderly persons. An altered clinical presentation. Clin Geriatr Med 1992;8:713-9.
28. Loeb M, Bentley DW, Bradley S et al. Development of minimum criteria for the initiation of antibiotics in residents of long-term-care facilities: results of a consensus conference. Infect Control Hosp Epidemiol 2001;22:120-4.
29. Bentley DW, Bradley S, High K et al. Practice guideline for evaluation of fever and infection in long-term care facilities. J Am Geriatr Soc 2001;49:210-22
30. Nicolle LE. Asymptomatic bacteriuria in institutionalized elderly people: evidence and practice. CMAJ 2000;163:285-6.
31. Pickering TD, Gurwitz JH, Zaleznik D et al. The appropriateness of oral fluoroquinolone-prescribing in the long-term care setting. J Am Geriatr Soc 1994;42:28-32.
32. Walker S, McGeer A, Simor AE et al. Why are antibiotics prescribed for asymptomatic bacteriuria in institutionalized elderly people? A qualitative study of physicians' and nurses' perceptions. CMAJ 2000;163:273-7.
33. Nicolle LE, Mayhew WJ, Bryan L. Prospective randomized comparison of therapy and no therapy for asymptomatic bacteriuria in institutionalized elderly women. Am J Med 1987;83:27-33.
34. Ouslander JG, Schapira M, Schnelle JF et al. Does eradicating bacteriuria affect the severity of chronic urinary incontinence in nursing home residents? Ann Intern Med 1995;122:749-54.
35. Abrutyn E, Mossey J, Berlin JA et al. Does asymptomatic bacteriuria predict mortality and does antimicrobial treatment reduce mortality in elderly ambulatory women? Ann Intern Med 1994;120:827-33.
36. Goldrick BA. Infection control programs in skilled nursing long-term care facilities: an assessment, 1995. Am J Infect Control 1999;27:4-9.
37. Centers for Disease Control and Prevention. CDC campaign to prevent antimicrobial resistance in heathcare settings. Available at http://www.cdc.gov/drugresistance/healthcare/Itc/12steps_Itc.htm. Accessed March 3, 2006.
38. Srinivasan A, Song X, Richards A et al. A survey of knowledge, attitudes, and beliefs of house staff physicians from various specialties concerning antimicrobial use and resistance. Arch Intern Med 2004;164:1451-6.
39. Weinstein R. Antimicrobial resistance: pushing back the tide with gloves, hand hygiene, and antibiotic recycling. 4th Decennial International Conference on Nosocomial Health-care - Associated Infections, Atlanta, Georgia, March 5-9, 2000. Available at Http://medscape. com/viewprogram/891_pnt.Accessed February 21, 2006.
40. Thompson BL, Dwyer DM, Ussery XT et al. Handwashing and glove use in a long-term-care facility. Infect Control Hosp Epidemiol 1997;18:97-103.
41. Akyol A, Ulusoy H, Ozen I, Handwashing: a simple, economical and effective method for preventing nosocomial infections in intensive care units. J Hosp Infect. 2006;62:395-405.
42. Edel E, Houston S, Kennedy V, LaRocco M. Impact of a 5-minute scrub on the microbial flora found on artificial, polished, or natural fingernails of operating room personnel. Nurs Res 1998;47:54-9.
43. Redd SC, Markowitz LE, Katz SL. Measles vaccine. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia, PA: WB. Saunders Company; 1999:222-226.
44. Orenstein WH, Hinman AR, Rodewald LE. Public health considerations in the United States. In: Plotkin SA, Orenstein WA, eds. Vaccines. 3rd ed. Philadelphia, PA: W.B. Saunders Company; 1999:1006-1032.
45. Dowdle WR, Hopkins DR, eds. The eradication of infectious diseases: Dahlem workshop report. Chichester, UK: John Wiley and Sons; 1997:1-218.
46. Centers for Disease Control and Prevention. Guidelines and recommendations, infection control measures for preventing and controlling influenza transmission in long-term care facilities. Available at http://www.cdc. gov/flu/professionals/infectioncontrol/pdf/Ion gtermcare.pdf. Accessed March 5, 2006.
47. Projan SJ, Shlaes DM. Antibacterial drug discovery: is it all downhill from here? Clin Microbiol Infect 2004;10(suppl 4):18-22.
48. Powers JH. Antimicrobial drug development-the past, the present, and the future. Clin Microbiol Infect 2004;10(suppl 4):23-31.